These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29376891)

  • 41. Effects of exenatide on weight and appetite in overweight adolescents and young adults with Prader-Willi syndrome.
    Salehi P; Hsu I; Azen CG; Mittelman SD; Geffner ME; Jeandron D
    Pediatr Obes; 2017 Jun; 12(3):221-228. PubMed ID: 27071367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The consequences of hyperphagia in people with Prader-Willi Syndrome: A systematic review of studies of morbidity and mortality.
    Bellis SA; Kuhn I; Adams S; Mullarkey L; Holland A
    Eur J Med Genet; 2022 Jan; 65(1):104379. PubMed ID: 34748997
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi syndrome.
    DelParigi A; Tschöp M; Heiman ML; Salbe AD; Vozarova B; Sell SM; Bunt JC; Tataranni PA
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5461-4. PubMed ID: 12466337
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Caregiver priorities for endpoints to evaluate treatments for Prader-Willi syndrome: a best-worst scaling.
    Tsai JH; Scheimann AO; McCandless SE; Strong TV; Bridges JFP
    J Med Econ; 2018 Dec; 21(12):1230-1237. PubMed ID: 30256699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identifying key underlying regulatory networks and predicting targets of orphan C/D box
    Gilmore RB; Liu Y; Stoddard CE; Chung MS; Carmichael GG; Cotney J
    bioRxiv; 2023 Oct; ():. PubMed ID: 37873184
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prader-Willi syndrome as a model of human hyperphagia.
    Tauber M; Diene G; Mimoun E; Çabal-Berthoumieu S; Mantoulan C; Molinas C; Muscatelli F; Salles JP
    Front Horm Res; 2014; 42():93-106. PubMed ID: 24732928
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Variability and change over time of weight and BMI among adolescents and adults with Prader-Willi syndrome: a 6-month text-based observational study.
    Vrana-Diaz CJ; Balasubramanian P; Kayadjanian N; Bohonowych J; Strong TV
    Orphanet J Rare Dis; 2020 Sep; 15(1):233. PubMed ID: 32883323
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Obesity management in Prader-Willi syndrome.
    Salehi P; Leavitt A; Beck AE; Chen ML; Roth CL
    Pediatr Endocrinol Rev; 2015 Mar; 12(3):297-307. PubMed ID: 25962207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting the histone methyltransferase G9a activates imprinted genes and improves survival of a mouse model of Prader-Willi syndrome.
    Kim Y; Lee HM; Xiong Y; Sciaky N; Hulbert SW; Cao X; Everitt JI; Jin J; Roth BL; Jiang YH
    Nat Med; 2017 Feb; 23(2):213-222. PubMed ID: 28024084
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased alternate splicing of Htr2c in a mouse model for Prader-Willi syndrome leads disruption of 5HT
    Garfield AS; Davies JR; Burke LK; Furby HV; Wilkinson LS; Heisler LK; Isles AR
    Mol Brain; 2016 Dec; 9(1):95. PubMed ID: 27931246
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader-Willi syndrome.
    Kuppens RJ; Diène G; Bakker NE; Molinas C; Faye S; Nicolino M; Bernoux D; Delhanty PJ; van der Lely AJ; Allas S; Julien M; Delale T; Tauber M; Hokken-Koelega AC
    Endocrine; 2015 Dec; 50(3):633-42. PubMed ID: 25989955
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Working-for-Food Behaviors: A Preclinical Study in Prader-Willi Mutant Mice.
    Lassi G; Maggi S; Balzani E; Cosentini I; Garcia-Garcia C; Tucci V
    Genetics; 2016 Nov; 204(3):1129-1138. PubMed ID: 27672097
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantifying the Burden of Hyperphagia in Prader-Willi Syndrome Using Quality-Adjusted Life-years.
    Lavelle TA; Crossnohere NL; Bridges JFP
    Clin Ther; 2021 Jul; 43(7):1164-1178.e4. PubMed ID: 34193348
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phylogenetic and Molecular Analyses Identify SNORD116 Targets Involved in the Prader-Willi Syndrome.
    Baldini L; Robert A; Charpentier B; Labialle S
    Mol Biol Evol; 2022 Jan; 39(1):. PubMed ID: 34893870
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Two patients with chromosome 22q11.2 deletion presenting with childhood obesity and hyperphagia.
    Bassett JK; Chandler KE; Douzgou S
    Eur J Med Genet; 2016 Aug; 59(8):401-3. PubMed ID: 27184501
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings.
    Angulo MA; Butler MG; Cataletto ME
    J Endocrinol Invest; 2015 Dec; 38(12):1249-63. PubMed ID: 26062517
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Understanding the causes of obesity in children with trisomy 21: hyperphagia vs physical inactivity.
    Foerste T; Sabin M; Reid S; Reddihough D
    J Intellect Disabil Res; 2016 Sep; 60(9):856-64. PubMed ID: 26936540
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel deletion of SNURF/SNRPN exon 1 in a patient with Prader-Willi-like phenotype.
    Cao Y; AlHumaidi SS; Faqeih EA; Pitel BA; Lundquist P; Aypar U
    Eur J Med Genet; 2017 Aug; 60(8):416-420. PubMed ID: 28554868
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neural mechanisms underlying hyperphagia in Prader-Willi syndrome.
    Holsen LM; Zarcone JR; Brooks WM; Butler MG; Thompson TI; Ahluwalia JS; Nollen NL; Savage CR
    Obesity (Silver Spring); 2006 Jun; 14(6):1028-37. PubMed ID: 16861608
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Disorders of hypothalamic function: Insights from Prader-Willi syndrome and the effects of craniopharyngioma.
    Whittington JE; Holland AJ
    Handb Clin Neurol; 2021; 181():381-389. PubMed ID: 34238472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.